Advertisement

Reactions Weekly

, Volume 1735, Issue 1, pp 162–162 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Pancreatic atrophy and immune-related adverse events: 31 case reports
Case report
  • 3 Downloads

Reference

  1. Eshet Y, et al. Clinical significance of pancreatic atrophy induced by immune-checkpoint inhibitors: A case-control study. Cancer Immunology Research 6: 1453-1458, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1158/2326-6066.CIR-17-0659 - IsraelCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations